Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F5QD2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,140
Award facts
- Contract value 100% obligated
- $12,139.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,139.76 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with a completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The place of performance is located at the contractor's corporate office in Conshohocken, PA.
This delivery order supports the Defense Health Agency and other federal healthcare systems' procurement needs for specialty pharmaceuticals. Enbrel is a biologic immunosuppressant medication used primarily for rheumatoid arthritis and other inflammatory conditions, making this order part of AmerisourceBergen's broader responsibility under its $999,999,999.00 comprehensive pharmaceutical IDC with DLA Troop Support Medical, which extends through December 2026. As a major pharmaceutical vendor, AmerisourceBergen maintains extensive capabilities to supply brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26F5QD2?
SPE2DR26F5QD2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F5QD2 worth?
The government has obligated $12,140 on SPE2DR26F5QD2.
Is contract SPE2DR26F5QD2 an order under another contract?
Yes. SPE2DR26F5QD2 is a delivery order under SPE2DR25D3003, an indefinite delivery contract.
Was contract SPE2DR26F5QD2 competed?
The extent of competition for SPE2DR26F5QD2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award